DNA-Doubled Cells' Survival Secret Unlocked: New Study
Baca dalam 60 detik
- Cells with double the normal DNA content typically self-destruct via apoptosis, but some survive and proliferate, fueling tumor growth.
- Researchers identified a key protein that stabilizes these cells by inhibiting death signals.
- This protein acts as a survival 'off switch' for the cell death pathway.
Cells with double the normal DNA content typically self-destruct via apoptosis, but some survive and proliferate, fueling tumor growth. Researchers identified a key protein that stabilizes these cells by inhibiting death signals. This protein acts as a survival 'off switch' for the cell death pathway.
The finding explains how polyploid cells—common in aggressive cancers—resist chemotherapy that relies on inducing apoptosis. By understanding this mechanism, scientists can design drugs to disable the survival protein. Clinical trials could begin within five years, targeting treatment-resistant tumors.
This study shifts the paradigm from simply killing dividing cells to specifically targeting their survival machinery. The approach promises fewer side effects and higher efficacy against stubborn cancers. Data from the study shows a 70% reduction in tumor viability in lab models when the protein is blocked.
Power Move: This isn't just a biology breakthrough—it's a strategic weapon against cancer's defense systems. The next wave of oncology will focus on disabling survival pathways, not just attacking growth. Expect Big Pharma to race for patents on this protein's inhibitors.
This article was edited with AI assistance for readability. Read original here.
